HPK1 antagonists and uses thereof
US12252488B2 · kind B2 · utility
0Cited by
21References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2022 |
| Grant date | Mar 18, 2025 |
| Priority date | — |
| Expiry date | Feb 11, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.